Remedent, Inc. Announces $7 Million Private Placement Financing

  
    
  
  
    
      Remedent, Inc. (OTCBB:REMI) announced today that it has sold 5.6 
      million shares of its common stock at a per share price of $1.25 in a 
      private placement with institutional investors. In addition to the 
      shares, the institutional investors will also receive warrants to 
      purchase an additional 4.2 million shares of common stock at an exercise 
      price of $1.55.
    
    
      Net proceeds to Remedent from the sale of the shares of common stock 
      will be approximately $6.2 million. The net proceeds will be used for 
      working capital and general corporate purposes and for setting up the 
      United States marketing and distribution activities for its new 
      revolutionary veneer technology, called GlamSmileTM.
    
    
      The lead investor in the private placement was Special Situations Fund 
      in New York. Other institutional investors included MicroCapital, LLC 
      and Potomac Capital Management, LLC.
    
    
      The shares of common stock being sold have not been registered under the 
      Securities Act of 1933, or any state securities laws, and will be sold 
      in a private transaction under Regulation D. Unless the shares are 
      registered, they may not be offered or sold in the United States except 
      pursuant to an exemption from the registration requirements of the 
      Securities Act and applicable state laws. Remedent is obligated to 
      register the shares being sold for resale on a registration statement to 
      be filed on or before July 20, 2007.
    
    
      This announcement is made pursuant to SEC Rule 135 and shall not 
      constitute an offer of any of the Company’s 
      securities by the Company or any of the institutional investors 
      participating in the private placement.
    
    
      About Remedent
    
    
      Remedent, Inc., a publicly listed company trading on the OTCBB, strives 
      to be a world leader in the research and development, manufacturing and 
      marketing of oral care and cosmetic dentistry products. Remedent 
      products are renowned for their technological superiority and 
      ease-of-use. Based in Deurle, Belgium, Remedent has successfully 
      researched, developed and manufactured all of its own products. These 
      products are now distributed in more than 35 countries worldwide. For 
      additional information, visit Remedent’s web 
      site at www.remedent.com
    
    
      FORWARD-LOOKING STATEMENTS
    
    
      "Safe Harbor" Statement under the Private Securities Litigation Reform 
      Act of 1995: The statements by Guy De Vreese, the statements regarding 
      growth of the GlamSmileTM product line, optimism 
      related to the business, expanding sales and other statements in this 
      press release are forward-looking statements within the meaning of the 
      Securities Litigation Reform Act of 1995. Such statements are based on 
      current expectations, estimates and projections about the Company's 
      business. Words such as expects, anticipates, intends, plans, believes, 
      sees, estimates and variations of such words and similar expressions are 
      intended to identify such forward-looking statements. These statements 
      are not guarantees of future performance and involve certain risks and 
      uncertainties that are difficult to predict. Actual results could vary 
      materially from the description contained herein due to many factors 
      including continued market acceptance of the Company's products. In 
      addition, actual results could vary materially based on changes or 
      slower growth in the oral care and cosmetic dentistry products market; 
      the potential inability to realize expected benefits and synergies; 
      domestic and international business and economic conditions; changes in 
      the dental industry; unexpected difficulties in penetrating the oral 
      care and cosmetic dentistry products market; changes in customer demand 
      or ordering patterns; changes in the competitive environment including 
      pricing pressures or technological changes; technological advances; 
      shortages of manufacturing capacity; future production variables 
      impacting excess inventory and other risk factors listed from time to 
      time in the Company's Securities and Exchange Commission filings under 
      "risk factors" and elsewhere. The forward-looking statements contained 
      in this press release speak only as of the date on which they are made, 
      and the Company does not undertake any obligation to update any 
      forward-looking statement to reflect events or circumstances after the 
      date of this press release.